Test of Herceptin Finds Briefer Treatment Can Work, With Fewer Side Effects
An aggressive type of breast cancer — a HER2-positive tumor — often shrinks with Herceptin treatment, but side effects can be tough. Researchers say a shorter course of the drug may be a good option.